BACKGROUND: Although trans fatty acids (TFAs) may increase the risk of dyslipidemia and coronary artery disease (CAD), limited data are available on their association with heart failure (HF). OBJECTIVE: Our goal was to assess associations of plasma and dietary TFAs with HF and CAD. DESIGN: We used a prospective, nested case-control design to select 788 incident HF cases and 788 matched controls from the Physicians' Health Study for biomarker analyses and a prospective cohort for the dietary analyses. Plasma fatty acids were assessed by using gas chromatography, and dietary intake was estimated by using a food-frequency questionnaire. Self-reported HF was ascertained by using annual follow-up questionnaires with validation in a subsample. We used conditional logistic (or Cox) regression to estimate multivariable-adjusted ORs (or HRs) for HF and CAD. RESULTS: Multivariable-adjusted ORs (95% CIs) for HF across consecutive quintiles of plasma trans 18:2 (linoleic acid) fatty acids were 1.0 (reference), 1.10 (0.79, 1.54), 0.88 (0.62, 1.25), 0.71 (0.49, 1.02), and 0.67 (0.45, 0.98) (P-trend = 0.01). Each SD of plasma trans 18:2 was associated with a 22% lower risk of HF (95% CI: 6%, 36%). Plasma trans 16:1 and 18:1 were not associated with risk of HF (P > 0.05). Dietary trans fats were not associated with incident HF or CAD. CONCLUSIONS: Our data are consistent with a lower risk of HF with higher concentrations of plasma trans 18:2 but not with trans 16:1 or trans 18:1 fatty acids in male physicians. Dietary TFAs were not related to incident HF or CAD.
RCT Entities:
BACKGROUND: Although trans fatty acids (TFAs) may increase the risk of dyslipidemia and coronary artery disease (CAD), limited data are available on their association with heart failure (HF). OBJECTIVE: Our goal was to assess associations of plasma and dietary TFAs with HF and CAD. DESIGN: We used a prospective, nested case-control design to select 788 incident HF cases and 788 matched controls from the Physicians' Health Study for biomarker analyses and a prospective cohort for the dietary analyses. Plasma fatty acids were assessed by using gas chromatography, and dietary intake was estimated by using a food-frequency questionnaire. Self-reported HF was ascertained by using annual follow-up questionnaires with validation in a subsample. We used conditional logistic (or Cox) regression to estimate multivariable-adjusted ORs (or HRs) for HF and CAD. RESULTS: Multivariable-adjusted ORs (95% CIs) for HF across consecutive quintiles of plasma trans 18:2 (linoleic acid) fatty acids were 1.0 (reference), 1.10 (0.79, 1.54), 0.88 (0.62, 1.25), 0.71 (0.49, 1.02), and 0.67 (0.45, 0.98) (P-trend = 0.01). Each SD of plasma trans 18:2 was associated with a 22% lower risk of HF (95% CI: 6%, 36%). Plasma trans 16:1 and 18:1 were not associated with risk of HF (P > 0.05). Dietary trans fats were not associated with incident HF or CAD. CONCLUSIONS: Our data are consistent with a lower risk of HF with higher concentrations of plasma trans 18:2 but not with trans 16:1 or trans 18:1 fatty acids in male physicians. Dietary TFAs were not related to incident HF or CAD.
Authors: Donald M Lloyd-Jones; Martin G Larson; Eric P Leip; Alexa Beiser; Ralph B D'Agostino; William B Kannel; Joanne M Murabito; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy Journal: Circulation Date: 2002-12-10 Impact factor: 29.690
Authors: L P van de Vijver; A F Kardinaal; C Couet; A Aro; A Kafatos; L Steingrimsdottir; J A Amorim Cruz; O Moreiras; W Becker; J M van Amelsvoort; S Vidal-Jessel; I Salminen; J Moschandreas; N Sigfússon; I Martins; A Carbajal; A Ytterfors; G Poppel Journal: Eur J Clin Nutr Date: 2000-02 Impact factor: 4.016
Authors: Rozenn N Lemaitre; Irena B King; Trivellore E Raghunathan; Rachel M Pearce; Sheila Weinmann; Robert H Knopp; Michael K Copass; Leonard A Cobb; David S Siscovick Journal: Circulation Date: 2002-02-12 Impact factor: 29.690
Authors: Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen Journal: JAMA Date: 2004-07-21 Impact factor: 56.272
Authors: Stephen J Mooney; Rozenn N Lemaitre; David S Siscovick; Philip Hurvitz; Charlene E Goh; Tanya K Kaufman; Garazi Zulaika; Daniel M Sheehan; Nona Sotoodehnia; Gina S Lovasi Journal: Health Place Date: 2018-08-16 Impact factor: 4.078
Authors: Nirupa R Matthan; Esther M Ooi; Linda Van Horn; Marian L Neuhouser; Richard Woodman; Alice H Lichtenstein Journal: J Am Heart Assoc Date: 2014-08-13 Impact factor: 5.501